QA: AYTU Biopharma INC in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001385818_2022_AYTU_Biopharma_INC.pdf

Logs

Graph

Absolute values for 0001385818, AYTU Biopharma INC

  xvar xval
0 AssetsCurrent 105,234,000
1 IntangibleAssetsNetIncludingGoodwill 151,266,000
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 9,168,000
4 LiabilitiesCurrent 109,438,000
5 LiabilitiesNoncurrent 18,482,000
6 remainder_Liabilities 180,000
7 CostOfGoodsAndServicesSold 177,136,155
8 SellingGeneralAndAdministrativeExpense 32,148,339
9 ResearchAndDevelopmentExpense 4,941,689
10 remainder_Expenses 247,399,045
11 remainder_Revenues 255,546,295
12 remainder_NetIncome 4,400,162
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 265,668,000
1 Liabilities 128,100,000
2 Expenses 461,625,228
3 Revenues 255,546,295
4 StockholdersEquity 137,568,000
5 NetIncome -201,678,771
6 ComprehensiveNetIncome -201,678,771
7 BaseVar 557,669,842
8 EconomicCapitalRatiobeforeLimitedLiability 0.499
9 EconomicCapitalRatio 1.88

Edgar->Model Mapping

Feature Distribution

Change over Time